Capvizr
THE DEAL, AT A GLANCE

Multiply Labs

2/4 reviewed
01
RoboticsTechnology
Robotics technology
What it doesMultiply Labs makes robots that automate sterile manufacturing steps for biological drugs.Source-grounded · automated review · Explore ↗

Checked 2026-10-06 · Review due 2026-10-13

Read supporting source ↗
Multiply Labs automates the entire…
02Who is involvedBacked by Elephant, Arthur Ventures, Updata PartnersFrom the announcement

Summarized from the deal record's source announcement; not yet independently reviewed.

Read the announcement ↗
03What happenedMultiply Labs raised $75M Series B, announced 2026-10-06From the announcement

Summarized from the deal record's source announcement; not yet independently reviewed.

Read the announcement ↗
04Why it mattersIts robots target lower-cost, higher-throughput production for advanced therapies.Interpretation · Explore ↗

Checked 2026-10-06 · Review due 2026-10-13

Read supporting source ↗
Your throughput increases by up…
Click a part to explore its evidence. Unsupported imagery is withheld rather than guessed.Original record source ↗

Multiply Labs · Financing Record

Explore source-linked visual explanations for Multiply Labs. Unsupported claims are withheld while source review continues.

Record 13505 · Recorded date: 2026-10-06

Explore company records →
Free weekday briefing

Know which funding rounds matter before the first call.

Source-linked rounds, lead investors, and the signal behind the capital. One five-minute read.

Free · Unsubscribe anytime